|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hou J, Meng F, Chan LW, Cho WC and Wong
SC: Circulating plasma microRNAs as diagnostic markers for NSCLC.
Front Genet. 7:1932016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H,
Liu X, Le H and Zhang Y: Diagnostic value of serum miR-182,
miR-183, miR-210, and miR-126 levels in patients with early-stage
non-small cell lung cancer. PLoS One. 11:e01530462016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scagliotti GV, Fossati R, Torri V, Crinò
L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F and
Tonato M: Adjuvant Lung Project Italy/European Organisation for
Research Treatment of Cancer-Lung Cancer Cooperative Group
Investigators: Randomized study of adjuvant chemotherapy for
completely resected stage I, II, or IIIA non-small-cell lung
cancer. J Natl Cancer Inst. 95:1453–1461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Navani N, Nankivell M, Lawrence DR, Lock
S, Makker H, Baldwin DR, Stephens RJ, Parmar MK, Spiro SG, Morris
S, et al Lung-BOOST trial investigators, : Lung cancer diagnosis
and staging with endobronchial ultrasound-guided transbronchial
needle aspiration compared with conventional approaches: An
open-label, pragmatic, randomised controlled trial. Lancet Respir
Med. 3:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bonatti M, Vezzali N, Lombardo F, Ferro F,
Zamboni G, Tauber M and Bonatti G: Gallbladder adenomyomatosis:
Imaging findings, tricks and pitfalls. Insights Imaging. 8:243–253.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aberle DR, Adams AM, Berg CD, Black WC,
Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM and Sicks
JD; National Lung Screening Trial Research Team, : Reduced
lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med. 365:395–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mehta AK, Hua K, Whipple W, Nguyen MT, Liu
CT, Haybaeck J, Weidhaas J, Settleman J and Singh A: Regulation of
autophagy, NF-κB signaling, and cell viability by miR-124 in KRAS
mutant mesenchymal-like NSCLC cells. Sci Signal. 10:102017.
View Article : Google Scholar
|
|
10
|
Wang RJ, Zheng YH, Wang P and Zhang JZ:
Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in
non-small cell lung cancer. Int J Clin Exp Pathol. 8:765–771.
2015.PubMed/NCBI
|
|
11
|
Mavridis K, Gueugnon F, Petit-Courty A,
Courty Y, Barascu A, Guyetant S and Scorilas A: The oncomiR miR-197
is a novel prognostic indicator for non-small cell lung cancer
patients. Br J Cancer. 112:1527–1535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Skjefstad K, Johannessen C, Grindstad T,
Kilvaer T, Paulsen EE, Pedersen M, Donnem T, Andersen S, Bremnes R,
Richardsen E, et al: A gender specific improved survival related to
stromal miR-143 and miR-145 expression in non-small cell lung
cancer. Sci Rep. 8:85492018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Novello S, Barlesi F, Califano R, Cufer T,
Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, et al ESMO
Guidelines Committee, : Metastatic non-small-cell lung cancer: ESMO
Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 27 Suppl 5:v1–v27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guisier F, Salaün M, Lachkar S, Lamy A,
Piton N, Obstoy B, Sabourin JC and Thiberville L: Molecular
analysis of peripheral non-squamous non-small cell lung cancer
sampled by radial EBUS. Respirology. 21:718–726. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Montani F, Marzi MJ, Dezi F, Dama E,
Carletti RM, Bonizzi G, Bertolotti R, Bellomi M, Rampinelli C,
Maisonneuve P, et al: miR-Test: A blood test for lung cancer early
detection. J Natl Cancer Inst. 107:djv0632015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang JS, Li BJ, Lu HW, Chen Y, Lu C, Zhu
RX, Liu SH, Yi QT, Li J and Song CH: Serum miR-152, miR-148a,
miR-148b, and miR-21 as novel biomarkers in non-small cell lung
cancer screening. Tumour Biol. 36:3035–3042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Molina R, Marrades RM, Augé JM, Escudero
JM, Viñolas N, Reguart N, Ramirez J, Filella X, Molins L and Agustí
A: Assessment of a combined panel of six serum tumor markers for
lung cancer. Am J Respir Crit Care Med. 193:427–437. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holdenrieder S, von Pawel J, Dankelmann E,
Duell T, Faderl B, Markus A, Siakavara M, Wagner H, Feldmann K,
Hoffmann H, et al: Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in
monitoring first-line chemotherapy of small cell lung cancer. Clin
Cancer Res. 14:7813–7821. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu
FQ, Hu R and Wang MS: miR-106a promotes growth and metastasis of
non-small cell lung cancer by targeting PTEN. Int J Clin Exp
Pathol. 8:3827–3834. 2015.PubMed/NCBI
|
|
22
|
Nadal E, Truini A, Nakata A, Lin J, Reddy
RM, Chang AC, Ramnath N, Gotoh N, Beer DG and Chen G: A novel serum
4-microRNA signature for lung cancer detection. Sci Rep.
5:124642015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zuberi M, Khan I, Mir R, Gandhi G, Ray PC
and Saxena A: Utility of serum miR-125b as a diagnostic and
prognostic indicator and its alliance with a panel of tumor
suppressor genes in epithelial ovarian cancer. PLoS One.
11:e01539022016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fiori ME, Barbini C, Haas TL, Marroncelli
N, Patrizii M, Biffoni M and De Maria R: Antitumor effect of
miR-197 targeting in p53 wild-type lung cancer. Cell Death Differ.
21:774–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Li F, Saha MN, Abdi J, Qiu L and
Chang H: miR-137 and miR-197 induce apoptosis and suppress
tumorigenicity by targeting MCL-1 in multiple myeloma. Clin Cancer
Res. 21:2399–2411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pekow J, Meckel K, Dougherty U, Butun F,
Mustafi R, Lim J, Crofton C, Chen X, Joseph L and Bissonnette M:
Tumor suppressors miR-143 and miR-145 and predicted target proteins
API5, ERK5, K-RAS, and IRS-1 are differentially expressed in
proximal and distal colon. Am J Physiol Gastrointest Liver Physiol.
308:G179–G187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ, et al: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
|
28
|
Mo D, Yang D, Xiao X, Sun R, Huang L and
Xu J: MiRNA-145 suppresses lung adenocarcinoma cell invasion and
migration by targeting N-cadherin. Biotechnol Lett. 39:701–710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al:
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor
gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen H, Shen J, Wang L, Shi Z, Wang M,
Jiang BH and Shu Y: Low miR-145 expression level is associated with
poor pathological differentiation and poor prognosis in non-small
cell lung cancer. Biomed Pharmacother. 69:301–305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shaker O, Maher M, Nassar Y, Morcos G and
Gad Z: Role of microRNAs −29b-2, −155, −197 and −205 as diagnostic
biomarkers in serum of breast cancer females. Gene. 560:77–82.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang H, Jiang Z, Xie G and Lu Y: Serum
microRNA-145 as a novel biomarker in human ovarian cancer. Tumour
Biol. 36:5305–5313. 2015. View Article : Google Scholar : PubMed/NCBI
|
